| Financial Year |
March 31 2023 |
| Monetary Funds |
2,509,855,028.02 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
21,950,210.76 |
| Accounts Receivable |
3,245,294,578.79 |
| Advances to Suppliers |
178,725,246.15 |
| Other Receivables |
1,066,043,644.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,155,078,239.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
99,384,179.12 |
| Total Current Assets |
8,276,331,127.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
75,150,786.21 |
| Investment Properties |
5,609,570,500.00 |
| Fixed Assetes |
649,181,197.94 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,673,470.37 |
| R&D expenses |
-- |
| Goodwill |
3,193,971,718.64 |
| Long-Term Deferred and Prepaid Expenses |
110,451,866.22 |
| Deferred Income Tax Assets |
41,009,002.70 |
| Other Non-Current Assets |
200,854,181.07 |
| Sub-Total of Non-Current Assets |
9,970,088,454.31 |
| Total Assets |
18,246,419,581.71 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,734,918,198.41 |
| Accounts Received In Advance |
9,635,897.38 |
| Employee Compensation Payable |
520,888,767.44 |
| Taxes Payable |
119,982,588.36 |
| Interest Payable |
-- |
| Dividend Payable |
48,801,108.16 |
| Other payables |
1,844,744,254.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,588,562,409.55 |
| Other Current Liabilities |
131,632,687.99 |
| Sub-Total of Current Liabilities |
6,741,905,420.40 |
| Long-term Loans |
1,136,100,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
56,826,659.39 |
| Special Payable |
-- |
| Estimatied Liabilities |
5,040,807.09 |
| Deferred Income Tax Liabilities |
733,132,847.83 |
| Other Non-Current Liabilities |
6,655,000.00 |
| Sub-Total of Non-Current Liabilities |
2,001,383,782.25 |
| Total Liabilities |
8,743,289,202.65 |
| Paid-In Capital(Or Share Stock) |
1,060,346,060.00 |
| Capital Surplus |
3,067,976,619.53 |
| Surplus Reserve |
506,573,262.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,699,524,188.18 |
| Minority Stockholder's Interest |
168,763,961.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,334,366,417.95 |
| Owner's Equity（Stockholder's Equity） |
9,503,130,379.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,246,419,581.71 |
